Today: 7 February 2026
Subscribe
Browse Category

NASDAQ:XRPC News 8 December 2025 - 8 January 2026

XRP price drops 5% after-hours as Ripple token rally cools; ETF flows, jobs report ahead

XRP price drops 5% after-hours as Ripple token rally cools; ETF flows, jobs report ahead

XRP fell 4.8% to $2.18 in after-hours trading Wednesday, tracking a broader decline in cryptocurrencies. Spot XRP ETFs have attracted about $1.3 billion since launching in November, according to SoSoValue data. Bitcoin dropped 2.2% to $90,995 and ether slid 3.7% to $3,149. Investors await Friday’s U.S. jobs report after ADP reported weaker-than-expected private payroll growth.
8 January 2026
···
XRP Price Forecast for December 2025: Extreme Fear, $2 “Buy Zone” Hype and $12M Max‑Pain Level Collide

XRP Price Forecast for December 2025: Extreme Fear, $2 “Buy Zone” Hype and $12M Max‑Pain Level Collide

On 7 December 2025, XRP found itself at a crossroads. The token is hovering around the $2.00 support zone after a two‑month, ~31% drawdown, while sentiment has sunk into “extreme fear” and analysts are split on whether this level is a bargain or a bull trap.Coinpaper+1 At the same time, XRP spot ETFs are approaching or surpassing $1 billion in assets, options data reveal a $12 million “max pain” level for bears near $2.28, and whale wallets have just offloaded roughly $783 million in XRP.Finbold+2U.Today+2 Here’s how the key narratives from 7 December 2025 fit together – and what they
8 December 2025
··

Stock Market Today

Eli Lilly stock pops as FDA targets cheap weight-loss copycats — what to know before Monday

Eli Lilly stock pops as FDA targets cheap weight-loss copycats — what to know before Monday

7 February 2026
New York, Feb 7, 2026, 10:22 EST — Market closed. Eli Lilly and Company shares closed Friday up $37.34, or 3.7%, at $1,058.18. The move came as U.S. regulators sharpened their tone on “compounded” weight-loss drugs — pharmacy-made versions meant for shortages or special patient needs that have morphed into mass-market alternatives. The FDA said it would take action against telehealth firm Hims & Hers over a $49 pill it marketed as a Wegovy-like option, and Lilly said it “applauded” the agency’s action. (Reuters) Why it matters now: obesity and diabetes medicines have become the growth engine for large drugmakers,
Saudi Aramco share price set for Sunday test after Tadawul ends market-making deal

Saudi Aramco share price set for Sunday test after Tadawul ends market-making deal

7 February 2026
Saudi Exchange approved Merrill Lynch KSA’s exit as market maker for Saudi Aramco, effective Feb. 8. Aramco shares closed at 25.60 riyals Thursday, down 0.06, with 22.1 million traded. The Tadawul index fell 1.3% as Brent crude dropped to $67.93. Aramco set March official selling prices at $2.10 above Argus for North America and $0.65 above ICE Brent for Western Europe.
Meta stock ends week down about 6% as Wall Street fixates on $135 billion AI capex

Meta stock ends week down about 6% as Wall Street fixates on $135 billion AI capex

7 February 2026
Meta closed down 1.3% Friday at $661.46, capping a 6.4% weekly drop as investors questioned heavy AI spending. Amazon and Alphabet also fell after outlining major capital outlays. Meta’s Instagram suffered a brief outage this week. Legal risks persist, with trials involving Meta set for next week in Los Angeles and New Mexico.
Go toTop